Has Daniel Larson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,831 in general payments to Daniel Larson, MD across 149 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Larson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Larson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Larson, MD

Otolaryngology · Dayton, OHNPI 1902068497

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Optinose US, Inc. at 37.1% of the total. Reporting peaked in 2019 at $3,758 and has fallen 73.1% since, to $1,012 in 2025. Among otolaryngology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,831in general payments, 2019–2025

Across 149 payments — averaging $59.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Optinose US, Inc.$3K
Inspire Medical Systems, Inc.$3K
Sanofi$809
Acclarent, Inc$542
Regeneron Healthcare Solutions, Inc.$370
Aerin Medical Inc.$228
plus $843 from 9 others

What the payments were for

Consulting fees$2,50028%
Travel & lodging$1,13613%
Food & beverage$5,19559%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Optinose US, Inc.	12	$3,280
Inspire Medical Systems, Inc.	49	$2,759
Sanofi	25	$809
Acclarent, Inc	17	$542
Regeneron Healthcare Solutions, Inc.	15	$370
Aerin Medical Inc.	10	$228
Stryker	4	$175
GSK	5	$166
Medtronic	2	$137
Phathom Pharmaceuticals, Inc.	1	$125
Checkpoint Surgical, Inc	1	$112
Vifor Pharma, Inc.	4	$53
ARS Pharmaceuticals Operations, Inc.	2	$36
Alk-abello, Inc	1	$25
AstraZeneca	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Xhance$2,989
Inspire Upper Airway Stimulation System$972
Inspire$671
DUPIXENT$130
VOQUEZNA$125
RELIEVA SPINPLUS Balloon Sinuplasty System$118
Checkpoint Stimulators$112

How this compares

$8,831 in reported general payments places this provider in the 90th percentile of 380 otolaryngology providers in Ohio.

See all otolaryngology providers in Ohio →

Medicare billing

Part B allowed, 2024

$172,180

Medicare patients

321

Services billed

1,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluticasone Propionate	124	$2,015
Ipratropium Bromide	21	$2,001
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	21	$1,801
Azelastine Hcl	39	$1,100
Omeprazole	86	$746
Triamcinolone Acetonide	18	$336
Levothyroxine Sodium	21	$217
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	13	$140
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	30	$121
Pantoprazole Sodium	12	$95
Mupirocin	19	$83
Methylprednisolone	16	$80
Cephalexin	23	$49
Azithromycin	14	$22

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Dayton

Atul BalwallyDayton$12K
Eric BauerDayton$4K
Raj SindwaniCleveland$598K
Mark MehleCleveland$403K
Troy WoodardCleveland$392K
Oliver AdunkaColumbus$338K
Subinoy DasColumbus$142K
Sanjeet RangarajanCleveland$113K
Sumit BapnaDublin$95K
Boris KaranfilovDublin$82K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →